Abstract |
Twenty-six patients with perennial rhinorrhea were treated by Atrovent, the anticholinergic agent, or placebo in a randomized double-blind crossover trial. The severity and duration of rhinorrhea were significantly reduced by Atrovent. Local side effects were more frequent with the active drug. These were reduced in a later open trial by a reduction in dosage.
|
Authors | A Knight, F Kazim, V A Salvatori |
Journal | Annals of allergy
(Ann Allergy)
Vol. 57
Issue 5
Pg. 348-54
(Nov 1986)
ISSN: 0003-4738 [Print] United States |
PMID | 2946252
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Atropine Derivatives
- Ipratropium
|
Topics |
- Administration, Intranasal
- Adolescent
- Adult
- Atropine Derivatives
(therapeutic use)
- Clinical Trials as Topic
- Double-Blind Method
- Female
- Humans
- Ipratropium
(administration & dosage, adverse effects, therapeutic use)
- Male
- Middle Aged
- Random Allocation
- Rhinitis, Vasomotor
(drug therapy)
|